Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03433040 · ClinicalTrials.gov registry record · Phase 3

17OHP-C Dosing Among Obese Pregnant Women

A Phase 3 study of Premature Birth and Absorption; Chemicals, sponsored by University of South Florida.

Completed
Registry status
Phase 3
Development phase
44
Enrollment target
2
Study locations

NCT03433040 is a Phase 3 study of Premature Birth and Absorption; Chemicals that has completed, run by University of South Florida. The registered enrollment target is 44 participants, below the 393-participant average among 38 other Premature Birth trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03433040, a Phase 3 study of Premature Birth and Absorption; Chemicals, has completed, sponsored by University of South Florida.

COMPLETED
Registry status
Phase 3
Development phase
44 participants
Enrollment target
2
Study locations

Study Summary

Emergency data suggest 17OHP-C may be less efficacious in obese women. Since obesity is associated with lower levels of plasma 17OHP-C, the investigator hypothesize that higher doses of 17OHP-C may help to prevent spontaneous PTB among obese women. The study aims to compare the pharmacokinetics of 17 OHP-C in obese compared with non-obese women.

Conditions Studied

Premature Birth Absorption; Chemicals

Interventions

  • DRUG 17-Hydroxyprogesterone Capronate

Study Locations (2)

Florida

  • University of South Florida - Tampa

Missouri

  • Washington University in St Louis - St Louis

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2017-08-23
Est. Completion 2021-07-14
Phase Phase 3

Sponsor

University of South Florida

252 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03433040

The ClinicalTrials.gov registry entry for NCT03433040 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 393-participant average among 38 other Premature Birth trials with a reported enrollment target (89% lower). The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Premature Birth appearing as the primary indexed condition, and to 1 intervention - of which 17-Hydroxyprogesterone Capronate is the first listed.

NCT03433040 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Missouri.

Frequently Asked Questions

What is clinical trial NCT03433040 about?

NCT03433040 is a clinical study titled "17OHP-C Dosing Among Obese Pregnant Women". Emergency data suggest 17OHP-C may be less efficacious in obese women. Since obesity is associated with lower levels of plasma 17OHP-C, the investigator hypothesize that higher doses of 17OHP-C may help to prevent spontaneous PTB among obese women. The study aims to compare the pharmacokinetics of 1...

What is the current status of trial NCT03433040?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 44 participants. The study started on 2017-08-23. Estimated completion is 2021-07-14.

What conditions does trial NCT03433040 study?

This clinical trial studies the following conditions: Premature Birth, Absorption; Chemicals.

What interventions are being tested in trial NCT03433040?

The interventions under investigation include: 17-Hydroxyprogesterone Capronate (DRUG).

Who is sponsoring clinical trial NCT03433040?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03433040 being conducted?

This trial has 2 study locations across Florida, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Premature Birth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Premature Birth

All registered trials for this condition

Absorption; Chemicals

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.